Acute respiratory failure: nursing assessment and interventions

Acute respiratory failure (ARF) is the inability of the respiratory system to maintain adequate gas exchange — oxygenation, ventilation, or both — to meet the body’s metabolic demands. It is defined by specific arterial blood gas criteria: a PaO2 below 60 mmHg (hypoxemia), a PaCO2 above 45 mmHg with accompanying hypoxemia (hypercapnia), or both. Without rapid recognition and intervention, ARF progresses to respiratory arrest and death. It is one of the most critical conditions a nurse will encounter, and it is a high-frequency NCLEX topic.

Understanding ARF requires mastery of two core concepts: the classification system (Type I vs Type II) and the physiological reasoning behind each intervention. This reference provides a comprehensive guide to both, covering causes, clinical presentation, ABG patterns, oxygen delivery, non-invasive ventilation, intubation criteria, medications, and NCLEX differentiation. Pair it with the ABG interpretation guide, the ARDS nursing reference, the mechanical ventilation nursing guide, and the COPD nursing reference — all four conditions overlap closely in critical care.

Defining acute respiratory failure

Acute respiratory failure occurs when the lungs cannot perform their fundamental functions: delivering oxygen to the blood and removing carbon dioxide. Clinically, ARF is defined by ABG criteria rather than symptoms alone:

• Hypoxemic ARF: PaO2 < 60 mmHg on room air (or PaO2/FiO2 ratio < 300 mmHg)
• Hypercapnic ARF: PaCO2 > 45 mmHg with accompanying hypoxemia and respiratory acidosis (pH < 7.35)
• Combined ARF: Both criteria present simultaneously — the most severe form

The onset distinguishes acute from chronic. Acute failure develops within minutes to hours; chronic failure (as in end-stage COPD) develops over months to years and may be partially compensated. Acute-on-chronic is the most complex presentation: a patient with chronically elevated PaCO2 who decompensates further, and whose “normal” baseline is already outside standard reference ranges. For nursing assessment, a baseline ABG — when available — is essential context.

The two-type classification is the framework the NCLEX uses to test ARF, and it maps directly to clinical decision-making: which oxygen delivery device, whether to use BiPAP, whether supplemental oxygen alone will help, and what medications to prepare.

Type I: hypoxemic respiratory failure

Mechanism

Type I ARF is fundamentally an oxygenation problem. The lungs fail to transfer oxygen from the alveoli into the pulmonary circulation efficiently. Three mechanisms drive this:

Ventilation-perfusion (V/Q) mismatch is the most common cause. In a normal lung, ventilation and perfusion are matched — alveoli receive both air and blood flow. When alveoli are ventilated but not perfused (V/Q > 1, dead space), or perfused but not ventilated (V/Q < 1, shunt), gas exchange is impaired. The shunt fraction is the proportion of cardiac output that bypasses ventilated alveoli and returns to the systemic circulation deoxygenated.

True shunt is the extreme end of V/Q mismatch: alveoli are completely collapsed or flooded and receive zero ventilation. The defining characteristic of shunt physiology is that supplemental oxygen does not correct hypoxemia — because no oxygen reaches the collapsed alveoli to enrich the blood flowing through them. This is the hallmark of ARDS and is why 100% FiO2 may still leave a patient hypoxic.

Diffusion impairment occurs when the alveolar-capillary membrane thickens (as in pulmonary fibrosis) or surface area is lost, slowing oxygen transfer. This is less commonly the primary mechanism in acute ARF but contributes in several conditions.

Causes of Type I ARF

Type II: hypercapnic respiratory failure

Mechanism

Type II ARF is a ventilation problem. The lungs move insufficient air to clear the carbon dioxide produced by metabolism. CO2 accumulates in the blood (hypercapnia: PaCO2 > 45 mmHg), and because CO2 dissolves in water to form carbonic acid, the result is respiratory acidosis (pH < 7.35).

The alveolar ventilation equation explains the relationship: PaCO2 is inversely proportional to alveolar ventilation. Cut ventilation in half; PaCO2 doubles. Hypoventilation — whether from obstructed airways, weakened respiratory muscles, blunted central drive, or chest wall restriction — is the shared mechanism across all Type II causes.

Hypoxemia in Type II failure develops secondary to hypoventilation: as CO2 rises and displaces oxygen in the alveoli (per the alveolar gas equation), PaO2 falls. The oxygen problem is a consequence, not the primary mechanism.

Causes of Type II ARF

ABG interpretation in acute respiratory failure

The ABG interpretation guide provides the complete 5-step ROME method. This section focuses specifically on the ABG patterns characteristic of ARF and how to read them in clinical context.

Normal ABG values for reference:

• pH: 7.35–7.45
• PaCO2: 35–45 mmHg
• PaO2: 80–100 mmHg
• HCO3: 22–26 mEq/L
• SaO2: 95–100%

Critical clinical point: In a COPD patient with chronic CO2 retention, a “normal” PaCO2 of 40 mmHg may represent acute deterioration — if their baseline is 55–60 mmHg, a drop to 40 means they were initially hyperventilating (compensating) and are now tiring. Always compare to the patient’s known baseline before interpreting.

Clinical presentation

Signs and symptoms

ARF typically presents with a cluster of respiratory, neurological, and cardiovascular findings. The pace of deterioration depends on the type and cause.

Respiratory findings — both types:

• Dyspnea — often severe; patient may be unable to complete sentences
• Tachypnea — respiratory rate typically > 25–30 breaths/min
• Accessory muscle use — sternocleidomastoid, scalene muscles visible during inspiration
• Intercostal and suprasternal retractions in severe cases
• Paradoxical breathing (abdominal and chest move in opposite directions) — a sign of impending respiratory arrest from diaphragmatic failure
• Cyanosis — central (lips, mucous membranes) indicates severe hypoxemia (SpO2 typically < 85%)

Additional findings in Type I hypoxemia:

• Agitation and anxiety — often the first behavioral sign of hypoxemia before SpO2 changes
• Bilateral crackles (pulmonary edema, ARDS, pneumonia)
• Diminished or absent breath sounds (pneumothorax, massive atelectasis)

Additional findings in Type II hypercapnia (CO2 narcosis):

• Confusion and drowsiness — CO2 accumulation depresses the CNS; a patient becoming sleepy during an exacerbation is deteriorating
• Asterixis — the flapping hand tremor produced by metabolic encephalopathy from CO2 retention; ask the patient to extend both arms and hold — a flapping movement with inability to maintain posture indicates CO2 narcosis
• Bounding pulse and warm flushed skin — CO2 causes peripheral vasodilation and increased cardiac output
• Headache — CO2 is a cerebral vasodilator; increased cerebral blood flow causes throbbing headache
• Diaphoresis — from increased work of breathing and sympathetic activation

Late / preterminal signs in any ARF:

• Bradypnea and decreasing respiratory effort — the patient stops fighting, respiratory rate falls
• Cyanosis, pallor, diaphoresis
• Bradycardia and hypotension
• Loss of consciousness

Nursing assessment priorities

Primary survey: airway, breathing, circulation

ARF is managed with the primary survey (ABC) framework first. No assessment detail matters until airway patency and breathing adequacy are confirmed.

Airway: Is the airway open and maintained? Listen for stridor (upper airway obstruction), gurgling (secretions), or absent breath sounds. A patient who cannot protect their airway (GCS ≤ 8, loss of gag reflex) requires immediate escalation — the airway is not safe.

Breathing: Rate, depth, rhythm, symmetry. Auscultate all lung fields. Absent breath sounds on one side? Suspect pneumothorax or massive effusion. Bilateral crackles? Pulmonary edema or ARDS. Wheezing? Bronchospasm (asthma, COPD, anaphylaxis). Count the respiratory rate — do not estimate. A rate > 30 is ominous; a rate declining from 30 to 18 in a deteriorating patient may signal impending arrest, not improvement.

Circulation: Assess heart rate, blood pressure, capillary refill, skin color and temperature. Tachycardia in ARF is initially compensatory. Hypotension signals the need to consider septic shock, tension pneumothorax, massive PE, or cardiac dysfunction. Urine output ≥ 0.5 mL/kg/hr indicates adequate end-organ perfusion.

Monitoring

• Continuous SpO2 — essential but has limitations: pulse oximetry is inaccurate in poor perfusion, nail polish, motion artifact, and severe anemia (carboxyhemoglobin will read falsely normal in CO poisoning)
• ABG — gold standard for PaO2, PaCO2, pH, and HCO3. Obtain after initiating supplemental O2, after any ventilator change, and when clinical status changes
• End-tidal CO2 (EtCO2) — continuous non-invasive CO2 monitoring; normal EtCO2 is 35–45 mmHg. Rising EtCO2 in a spontaneously breathing patient indicates hypoventilation and CO2 retention
• Respiratory rate — counted manually for 60 seconds; the single most sensitive early warning sign for deterioration
• Mental status — confusion, agitation, drowsiness are all clinical indicators that must be reassessed continuously; any unexplained mental status change in a respiratory patient warrants ABG

Oxygen therapy and titration

Matching the oxygen delivery device to the clinical situation is a core nursing skill. The goal is to correct hypoxemia without causing harm — particularly in patients at risk for CO2 retention.

The hypoxic drive — understanding the risk in Type II COPD

The “hypoxic drive” concern in COPD deserves careful explanation because it is frequently misunderstood. In healthy patients, the primary stimulus for breathing is rising PaCO2 acting on central chemoreceptors. In patients with chronic hypercapnia (Type II COPD), these central receptors become blunted over time — they stop responding vigorously to CO2. These patients rely more on peripheral chemoreceptors (carotid and aortic bodies), which are stimulated by falling PaO2 (hypoxia). This is the hypoxic drive.

If aggressive supplemental oxygen eliminates all hypoxic stimulus, some COPD patients may reduce their respiratory effort, causing further CO2 retention. However, withholding oxygen from a hypoxic COPD patient is dangerous and wrong. The evidence-based target for COPD patients in ARF is SpO2 88–92% — enough to maintain adequate oxygen delivery while avoiding abolition of the hypoxic drive. Never withhold O2 from a cyanotic COPD patient; titrate it carefully.

Non-invasive ventilation (NIV)

Non-invasive ventilation delivers positive pressure via a tight-fitting mask, avoiding the complications of intubation. For appropriate candidates, NIV reduces intubation rates, ICU length of stay, and mortality.

BiPAP for Type II ARF

BiPAP is the first-line intervention for moderate-severe COPD exacerbation with hypercapnic respiratory failure. The evidence base is robust: multiple RCTs and the Cochrane Collaboration demonstrate that BiPAP in acute COPD exacerbation reduces intubation rates by approximately 50%, reduces mortality, and shortens hospital stay.

BiPAP delivers two pressure levels:

• IPAP (inspiratory positive airway pressure): Assists each inhalation — reduces the work of breathing and augments tidal volume, improving CO2 clearance
• EPAP (expiratory positive airway pressure): Maintains airway patency during exhalation — splints open airways and prevents alveolar collapse; equivalent to PEEP

Typical initial settings: IPAP 10–12 cmH2O / EPAP 4–5 cmH2O, titrated up based on respiratory rate, tidal volume, patient comfort, and ABG response.

BiPAP is also used in:

• Obesity hypoventilation syndrome
• Acute-on-chronic respiratory failure
• Cardiogenic pulmonary edema (when CPAP is unavailable or insufficient)

Contraindications to NIV

BiPAP/CPAP are contraindicated in situations where a tight mask seal cannot be maintained safely or where the patient cannot protect their airway:

• Inability to protect the airway — vomiting, massive hemoptysis, impaired cough and gag reflex; aspiration risk is high with positive pressure into an unprotected airway
• Altered mental status / agitation — a confused or combative patient will not tolerate or maintain a mask seal; risk of dislodging the mask mid-session
• Facial trauma or burns — mask cannot form a seal; lesions may worsen with pressure
• Hemodynamic instability — hypotension not responsive to fluids is a relative contraindication; positive pressure reduces venous return
• Recent upper GI surgery — risk of anastomotic leak or rupture with pressurized delivery
• Active vomiting — aspiration risk is acute and immediate

CPAP for Type I ARF

CPAP provides a single continuous pressure throughout the respiratory cycle. It recruits collapsed alveoli and reduces the work of breathing but does NOT augment tidal volume. It is appropriate for Type I ARF patients who:

• Have an intact respiratory drive and can breathe spontaneously
• Are not retaining CO2 (adding pressure to a hypoventilating patient worsens CO2 clearance inefficiency)
• Require alveolar recruitment — cardiogenic pulmonary edema and OSA are classic CPAP indications

Intubation criteria and escalation

Intubation and mechanical ventilation are required when non-invasive measures fail or when the clinical situation precludes them. Recognizing the intubation threshold is a core critical care nursing skill — preparation must happen before the patient arrests.

Criteria for escalation to mechanical ventilation:

• Failure of NIV — no improvement in respiratory rate, ABG, or mental status after 1–2 hours of BiPAP/CPAP; increasing work of breathing despite NIV
• GCS ≤ 8 — the patient cannot reliably protect the airway; aspiration risk is unacceptable
• PaO2 < 60 mmHg despite maximum non-invasive supplemental oxygen — refractory hypoxemia not corrected by any mask device or NIV
• Worsening hypercapnic acidosis — PaCO2 rising with pH < 7.25; this represents severe respiratory acidosis that increases myocardial irritability (arrhythmia risk) and depresses consciousness
• Apnea or near-apnea — respiratory rate < 8 with decreasing depth; the patient’s respiratory drive is failing
• Cardiorespiratory arrest — intubation is performed as part of resuscitation

Nursing preparation for rapid sequence intubation (RSI):

• Position patient supine with head of bed at 20–30° (allows laryngoscope access while providing some pre-oxygenation benefit)
• Pre-oxygenate with 100% FiO2 for 3–5 minutes via NRB or BVM — extends the safe apnea time
• Draw up medications: succinylcholine or rocuronium (neuromuscular blockade), etomidate or ketamine (induction), vasopressors to anticipate post-intubation hypotension
• Prepare suction, ETT (correct size + one size smaller), laryngoscope, stylet, 10 mL syringe (cuff inflation), tape or commercial securing device
• Attach continuous SpO2 and EtCO2 — waveform capnography confirms ETT placement (sustained waveform = tracheal placement)
• Notify respiratory therapy; have ventilator settings planned before intubation

Post-intubation management is covered in the mechanical ventilation nursing guide.

Nursing interventions

Positioning

Position has a direct effect on respiratory mechanics:

• Head of bed 30–45° for all intubated and mechanically ventilated patients (VAP prevention, reduces aspiration risk, improves diaphragm excursion by reducing abdominal pressure on the chest)
• Semi-recumbent or upright for non-intubated ARF patients — never supine; supine positioning reduces FRC and worsens oxygenation, particularly in obese patients
• Lateral positioning (good lung down) in unilateral lung disease — placing the better lung in the dependent position maximizes perfusion to the healthier tissue
• Prone positioning in severe ARDS (P/F < 150 mmHg) — covered in the ARDS nursing reference

Airway clearance

• Suctioning — perform when secretions are present (audible, visible, SpO2 dropping without other explanation); suction duration ≤ 10–15 seconds; hyperoxygenate before and after; note secretion color, consistency, quantity
• Incentive spirometry — for spontaneously breathing, conscious patients; prevents atelectasis; 10 repetitions per hour while awake
• Chest physiotherapy / percussion — for patients with bronchiectasis, CF, or productive secretions when cough is weak
• Nebulized bronchodilators — albuterol (SABA) for bronchospasm; ipratropium (anticholinergic) added for COPD exacerbation; administer via in-line nebulizer or MDI with spacer on NIV/ventilator circuit

Hemodynamic and metabolic monitoring

• Maintain continuous cardiac monitoring — arrhythmias are common in ARF (hypoxemia and hypercapnia both increase myocardial irritability)
• Monitor potassium closely — albuterol causes hypokalemia; COPD exacerbation patients often have diuretic-related hypokalemia at baseline
• Assess renal function — prerenal AKI is common when hypoxemia causes sympathetic-mediated renal vasoconstriction; monitor urine output and BUN/creatinine
• Fluid balance — restrictive in ARDS; cautious in COPD (excess fluid worsens pulmonary edema); aggressive resuscitation when sepsis is the underlying cause (see sepsis nursing guide)

Anxiety and communication

Dyspnea is terrifying. Patients in ARF experience profound anxiety that itself increases oxygen demand and worsens tachypnea. Nursing interventions:

• Remain calm and present — reassurance reduces tachypnea and anxiety in hypoxic patients
• Explain every procedure before doing it — even when the patient appears obtunded, explain aloud
• For intubated patients: establish a communication system before sedation is deepened — writing board, eye-blink signals, letter boards
• Avoid excessive sedation — over-sedation suppresses respiratory drive and prolongs mechanical ventilation

Medications commonly used in ARF

NCLEX differentiation: ARF vs related conditions

This table targets the most common NCLEX-tested differentials — conditions that share hypoxemia and dyspnea but require different priority interventions.

Complications to monitor

• Ventilator-associated pneumonia (VAP) — if intubated; prevented by the VAP bundle (HOB 30–45°, oral care, daily SBT assessment, cuff pressure maintenance); see mechanical ventilation nursing guide
• Barotrauma — pneumothorax, pneumomediastinum, subcutaneous emphysema from elevated airway pressures; monitor for sudden unilateral absent breath sounds, hypotension, tracheal deviation
• Oxygen toxicity — FiO2 > 0.60 sustained beyond 24–48 hours causes oxidative damage; always use lowest effective FiO2
• ICU-acquired weakness and delirium — prolonged mechanical ventilation, sedation, and immobility cause both; early mobilization and minimizing sedation are evidence-based preventive strategies
• Renal failure — prerenal AKI from reduced cardiac output + renal vasoconstriction; monitor urine output and creatinine daily; see AKI nursing reference
• GI stress ulcers — mechanical ventilation > 48 hours is a major risk factor; stress ulcer prophylaxis (pantoprazole or ranitidine per protocol) is standard
• Hemodynamic instability — positive pressure ventilation reduces venous return; anticipate hypotension after intubation (post-intubation hypotension); vasopressors may be required; norepinephrine is first-line in septic shock with ARF (see shock nursing reference)

Patient and family education

When the patient has stabilized — either extubated or weaned to low-level oxygen support — education focuses on the underlying cause and prevention of recurrence.

Underlying cause management:

• COPD: medication adherence (inhaled corticosteroid/LABA maintenance), action plan for exacerbations, when to call 911 (increasing dyspnea, unable to complete sentences, SpO2 falling), home BiPAP if prescribed
• Asthma: trigger avoidance, controller vs. rescue inhaler distinction, peak flow monitoring, action plan
• Opioid-induced ARF: naloxone kit education for patient and family; safe opioid storage; risk of relapse after tolerance reset
• Heart failure: daily weights, fluid restriction, diuretic adherence, sodium restriction; see heart failure nursing guide

For patients discharged on home oxygen:

• Flow rate and hours per day are prescribed — do not adjust without provider guidance
• Fire safety: no smoking, no open flames; oxygen supports combustion
• Nasal dryness and epistaxis — use humidified oxygen when possible; nasal saline as needed
• When to seek emergency care — defined SpO2 threshold and symptom list; never delay calling 911 if acutely short of breath

Smoking cessation: Smoking is the primary modifiable risk factor for COPD, lung cancer, and cardiovascular disease — all leading causes of ARF. Every hospitalization is an opportunity to initiate cessation counseling and pharmacotherapy (nicotine replacement, varenicline, bupropion). The hospitalized patient’s motivation is often highest during acute illness.

NCLEX tips

1. PaO2 < 60 mmHg = ARF. This is the threshold. Normal PaO2 is 80–100 mmHg. PaO2 60–79 mmHg is hypoxemia but does not meet the ARF definition. Commit this number.

2. Type I = oxygenation failure (V/Q mismatch / shunt). Type II = ventilation failure (CO2 cannot be cleared). The NCLEX tests whether you know which type is present and which intervention follows.

3. PaCO2 > 45 mmHg = Type II ARF. Rising CO2 means the patient cannot ventilate adequately. Falling pH with rising CO2 = decompensated respiratory acidosis.

4. Shunt does NOT respond to 100% supplemental oxygen. This distinguishes ARDS from simple V/Q mismatch. A PaO2 that fails to rise appropriately with high-flow O2 suggests true shunt (ARDS, massive atelectasis).

5. BiPAP = first-line for COPD exacerbation with hypercapnia. This is one of the highest-yield NCLEX answers in respiratory failure. If the question says COPD + rising CO2 + SpO2 88% on 2L NC — the next intervention is BiPAP, not intubation.

6. SpO2 target in COPD = 88–92%. Higher targets in chronic hypercapnic COPD patients risk suppressing the hypoxic drive and worsening CO2 retention. 94–98% is the standard target for most other patients.

7. Normal pH in a COPD patient does not mean the patient is stable. A pH of 7.37 with PaCO2 of 68 and HCO3 of 38 represents fully compensated chronic respiratory acidosis — this patient lives in this state. An acute rise to PaCO2 75 may not change the pH significantly but represents decompensation.

8. Asterixis = CO2 narcosis. This flapping hand tremor indicates hypercapnic encephalopathy. Assess by having the patient extend arms — inability to maintain posture with flapping = positive asterixis.

9. BiPAP is contraindicated with vomiting. A patient who is actively vomiting cannot safely tolerate positive pressure with a tight-fitting face mask. Remove the mask immediately; suction first.

10. Intubation threshold: pH < 7.25 with rising PaCO2. When pH falls below 7.25 in respiratory failure, the acidosis is severe enough to cause myocardial depression and arrhythmias. This is the critical threshold where intubation discussion becomes urgent.

11. Naloxone duration is shorter than most opioids. A patient who responds to naloxone can re-narcotize when naloxone wears off (30–90 min). Monitor for 4–6 hours after last dose; consider naloxone infusion for long-acting opioid overdose.

12. ARDS is non-cardiogenic pulmonary edema; PAWP ≤ 18 mmHg differentiates it from heart failure. The NCLEX will present both conditions with bilateral infiltrates and hypoxemia. The distinguishing lab/hemodynamic finding is PAWP.

13. Rising respiratory rate with falling SpO2 = early ARF. Tachypnea is the most sensitive early sign; wait for SpO2 to fall and you have lost time. Respond to tachypnea plus work of breathing, not SpO2 alone.

14. Mental status change in a hypoxic patient is a clinical emergency. New confusion, agitation, or drowsiness in a patient with respiratory disease requires immediate ABG and reassessment of oxygen therapy. Do not attribute confusion to anxiety or sedation without ruling out hypoxemia and hypercapnia.

15. FiO2 > 0.60 for > 24–48 hours causes oxygen toxicity. Titrate down as quickly as oxygenation allows. Always use lowest effective FiO2 — especially after intubation.

NCLEX-style practice questions

Question 1

A patient with known COPD presents to the emergency department with worsening dyspnea. SpO2 is 84% on room air. ABG shows: pH 7.29, PaCO2 62 mmHg, PaO2 48 mmHg, HCO3 28 mEq/L. What is the nurse’s priority intervention?

A) Apply a non-rebreather mask at 15 L/min to correct hypoxemia rapidly
B) Prepare the patient for immediate intubation
C) Apply BiPAP and titrate supplemental oxygen to achieve SpO2 88–92%
D) Administer IV methylprednisolone and repeat the ABG in 4 hours

Answer: C — BiPAP with controlled oxygen titration

Rationale: This patient has Type II ARF (PaCO2 > 45, pH < 7.35, hypoxemia) in the setting of COPD. BiPAP is the first-line intervention for COPD exacerbation with hypercapnic respiratory failure. It reduces work of breathing, improves CO2 clearance, and reduces intubation rates by ~50%. Controlled oxygen targeting SpO2 88–92% avoids suppressing the hypoxic drive. Option A is incorrect — a non-rebreather at 15 L/min would push SpO2 above 92% in most cases, risking further CO2 retention. Option B is premature — NIV should be trialed first unless contraindicated. Option D (steroids + wait) is an appropriate adjunct but is not the priority intervention for a patient with SpO2 84%.

Question 2

A nurse is caring for a patient who received IV hydromorphone 15 minutes ago. The patient now has a respiratory rate of 6 breaths/minute and is unresponsive. SpO2 is 82%. What is the nurse’s first action?

A) Draw an ABG to confirm the diagnosis
B) Administer naloxone and prepare for airway management
C) Increase supplemental oxygen to non-rebreather at 15 L/min
D) Call the rapid response team, then prepare BiPAP

Answer: B — Administer naloxone and prepare for airway management

Rationale: This presentation is consistent with opioid-induced respiratory depression (Type II ARF) — recent opioid administration, bradypnea (RR 6), loss of consciousness. Naloxone (0.4 mg IV/IM/SC) is the specific reversal agent and should be given immediately while simultaneously preparing for possible airway management (BVM ventilation, intubation). Supplemental oxygen alone will not reverse the central respiratory depression. BiPAP is contraindicated in an unresponsive patient who cannot protect the airway. Obtaining an ABG is appropriate but is not the first action — reversal and airway management take precedence.

Question 3

A nurse is caring for a mechanically ventilated patient with ARDS. The current ABG shows: pH 7.28, PaCO2 52 mmHg, PaO2 58 mmHg, HCO3 23 mEq/L. Ventilator settings: Vt 420 mL (6 mL/kg IBW), FiO2 0.65, PEEP 10 cmH2O. Which finding is most consistent with appropriate lung-protective management?

A) The tidal volume is too high and should be increased to normalize PaCO2
B) The elevated PaCO2 indicates permissive hypercapnia consistent with lung-protective ventilation
C) FiO2 should be increased to 1.0 to correct hypoxemia before addressing the acidosis
D) The patient should be extubated because the respiratory acidosis indicates ventilator dyssynchrony

Answer: B — Elevated PaCO2 reflects permissive hypercapnia, consistent with lung-protective ventilation

Rationale: Lung-protective ventilation targets 6 mL/kg IBW and plateau pressure < 30 cmH2O, even at the cost of mild hypercapnia. Permissive hypercapnia (PaCO2 elevated with pH 7.20–7.45) is accepted rather than increasing tidal volume to normalize CO2 — doing so would worsen volutrauma. Option A is incorrect — increasing Vt worsens lung injury. Option C is incorrect — FiO2 should be titrated to the lowest effective level; maximizing FiO2 risks oxygen toxicity and does not address the CO2 problem. Option D is incorrect — the patient is in active ARF; extubation is not indicated.

Related references

Conditions that frequently present with acute respiratory failure or are caused by it:

• ABG interpretation guide — essential for classifying ARF type and monitoring response to treatment; includes the 5-step ROME method
• ARDS nursing reference — the most severe form of Type I ARF; Berlin Definition, P/F ratio, prone positioning, lung-protective ventilation
• Mechanical ventilation nursing guide — comprehensive reference for intubated ARF patients; modes, settings, alarms, weaning, VAP bundle
• COPD nursing reference — the leading cause of Type II ARF; exacerbation management, BiPAP indications, hypoxic drive, spirometry
• Asthma nursing guide — status asthmaticus is a cause of Type II ARF; stepwise treatment, heliox, magnesium
• Pneumonia nursing guide — the most common direct cause of Type I ARF; community vs hospital-acquired, antibiotic selection
• Pulmonary embolism nursing reference — causes Type I ARF via dead-space physiology; Wells score, anticoagulation, massive PE management
• Heart failure nursing guide — cardiogenic pulmonary edema is a primary cause of Type I ARF; Frank-Starling, diuresis, afterload reduction
• Sepsis nursing reference — sepsis is the leading indirect cause of ARF and ARDS; Sepsis-3 criteria, fluid resuscitation, vasopressors
• Shock nursing reference — distributive, cardiogenic, obstructive shock all produce ARF; hemodynamic targets, vasopressor selection

This article is for educational purposes. Always apply clinical judgment and follow your institution’s evidence-based protocols when caring for patients with acute respiratory failure.